Synergistic activation of NF-κB by tumor necrosis factor alpha and gamma interferon via enhanced IκBα degradation and de novo IκBβ degradation

Molecular and Cellular Biology

Volumn 17, Issue 11, 1997, Pages 6746-6754

  Cheshire, Jeanette L ^a   Baldwin Jr , Albert S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CYTOPLASM; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOBLOTTING; NERVE CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

EID: 0030764347     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.11.6746     Document Type: Article

References (83)

1. Aggarwal, B. B., T. E. Eessalu, and P. E. Hass. 1985. Characterization ot receptors for human tumor necrosis factor and their regulation by γ-interferon. Nature 318:665-667.
2. Akiyama, T., J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:5592-5595.
3. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
4. Baldwin, A. S., Jr., and P. A. Sharp. 1988. Two transcription factors. NF-κB and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter. Proc. Natl. Acad. Sci. USA 85:723-727.
5. 1 transition in mouse fibroblasts. Mol. Cell. Biol. 11:4943-4951.
6. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
7. Bancroft, G. J., K. C. F. Sheehan, R. D. Schreiber, and E. R. Unanue. 1989. Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in SCID mice. J. Immunol. 143:127-130.
8. Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and families. N. Engl. J. Med. 334:1717-1725.
9. Beg, A., W. Sha, R. Bronson, and D. Baltimore. 1995. Constitutive NF-κB activation, enhanced granulopoiesis and neonatal lethality in IκBα deficient mice. Genes Dev. 9:2736-2746.
10. Beg, A., W. Sha, R. Bronson, S. Ghosh, and D. Baltimore. 1993. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-170.
11. Beg, A. A., S. M. Rubin, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin, Jr. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6:1899-1913.
12. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301-3310.
13. Beutler, B. 1995. TNF, immunity and inflammatory disease: lessons of the past decade. J. Invest. Med. 43:227-235.
14. Blanchet, O., J. F. Bourge, H. Zinszner, Z. Tatari, L. Degos, and P. Paul. 1991. DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC-class-I transcriptional level in class-I-defective cell lines. Int. J. Cancer 6(Suppl.):138-145.
15. Brockman, J. A., D. C. Scherer, T. A. McKinsey, S. M. Hall, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809-2818.
16. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
17. Buchmeier, N. A., and R. D. Schreiber. 1985. Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci. USA 87:7404-7408.
18. Burkly, L., C. Hession, L. Ogata, C. Reilly, L. Marconi, D. Olsen, R. Tizard, R. Cate, and D. Lo. 1995. Expression of RelB is required for the development of thymic medulla and dendritic cells. Nature 373:531-536.
19. Chen, Z., J. Hagler, V. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
20. Chen, Z. J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862.
21. 20a. Cheshire, J. L., and A. S. Baldwin, Jr. Unpublished data.
22. Cogswell, P. C., M. W. Mayo, and A. S. Baldwin, Jr. 1997. Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-α-induced NF-κB1 transcription. J. Exp. Med. 185:491-497.
23. Collins, T., H. J. Palmer, M. Z. Whitley, A. S. Neish, and A. J. Williams. 1993. A common theme in endothelial activation. Insights from the structural analysis of the genes for E-selectin and VCAM-1. Trends Cardiovasc. Med. 3:92-97.
24. Collins, T., M. A. Read, A. S. Neish, M. Z. Whitley, D. Thanos, and T. Maniatis. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9:899-909.
25. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffen, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in IFNγ gene-disrupted mice. J. Exp. Med. 178:2243-2248.
26. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
27. Doukas, J., and J. S. Pober. 1990. IFN-γ enhances endothelial activation induced by tumor necrosis factor but not IL-1. J. Immunol. 145:1727-1733.
28. Drew, P. D., G. Franzoso, K. G. Becker, V. Bours, L. M. Carlson, U. Siebenlist, and K. Ozato. 1995. NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J. Interferon Cytokine Res. 15:1037-1045.
29. Edgell, C.-J. S., C. C. McDonald, and J. B. Graham. 1983. Permanent cell line expressing factor VIII related antigen established by hybridization. Proc. Natl. Acad. Sci. USA 80:3734-3737.
30. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11:571-611.
31. Finco, T. S., and A. S. Baldwin, Jr. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3:263-272.
32. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. K. Stewart, and B. R. Bloom. 1993. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
33. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572.
34. Gashler, A., and V. P. Sukhatme. 1995. Early growth response protein 1 (EGR-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 50:191-224.
35. Greene, L. A., and A. S. Tischler. 1976. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73:2424-2428.
36. Greene, L. A., and A. S. Tischler. 1982. PC12 pheochromocytoma cultures in neurobiological research. Adv. Cell. Neurobiol. 3:373-414.
37. Harhaj, E. W., S. B. Maggirwar, L. Good, and S.-C. Sun. 1996. CD28 mediates a potent costimulatory signal for rapid degradation of IκBβ which is associated with accelerated activation of various NF-κB/Rel heterodimers. Mol. Cell. Biol. 16:6736-6743.
38. Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, K. Mondal, P. Ralph, and A. S. Baldwin, Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281-1289.
39. Havell, E. A. 1989. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 143:2894-2899.
40. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259:1742-1745.
41. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331-334.
42. Jahnke, A., and J. P. Johnson. 1994. Synergistic activation of intercellular adhesion molecule 1 (ICAM-1) by TNF-α and IFN-γ is mediated by p65/p50 and p65/c-Rel and interferon-responsive factor Stat1α (p91) that can be activated by both IFN-γ and IFN-α. FEBS Lett. 354:220-226.
43. Johnson, D. R., and J. S. Pober. 1994. HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol. Cell. Biol. 14:1322-1332.
44. Johnson, D. R., I. Douglas, A. Jahnke, S. Ghosh, and J. S. Pober. 1996. A sustained reduction in IκB-β may contribute to persistent NF-κB activation in human endothelial cells. J. Biol. Chem. 271:16317-16322.
45. Kaltschmidt, B., P. A. Baeuerle, and C. Kaltschmidt. 1993. Potential involvement of the transcription factor NF-κB in neurological disorders. Mol. Aspects Med. 14:171-190.
46. Kontgen, F., R. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-Rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and IL-2 expression. Genes Dev. 9:1965-1977.
47. Krakauer, T., and J. J. Oppenheim. 1993. IL-1 and tumor necrosis factor-alpha each up-regulate both the expression of IFN-gamma receptors and enhance IFN-gamma-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J. Immunol. 150:1205-1211.
48. Leenen, P. J. M., B. P. Canono, D. A. Drevets, J. S. A. Voerman, and P. A. Campbell. 1994. TNF-α and IFN-γ stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. J. Immunol. 153:5141-5147.
49. Liou, H. C., and D. Baltimore. 1993. Regulation of the NF-κB/Rel transcription factor and IκB inhibitor system. Curr. Opin. Cell Biol. 5:477-487.
50. Marfaing-Koka, A., O. Devergne, G. Gorgone, A. Portier, T. J. Schall, P. Galanaud, and D. Emilie. 1995. Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13. J. Immunol. 154:1870-1878.
51. Martin, E., C. Nathan, and Q.-W. Xie. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:977-984.
52. McKinsey, T. A., J. A. Brockman, D. C. Scherer, S. W. Al-Murrani, P. L. Green, and D. W. Ballard. 1996. Inactivation of IκBβ by the Tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-κB. Mol. Cell. Biol. 16:2083-2090.
53. Miyamoto, S., and I. Venna. 1995. Rel/NF-κB/IκB story. Adv. Cancer Res. 66:255-292.
54. Murphy, T. L., M. G. Cleveland, P. Kulesza, J. Magram, and K. M. Murphy. 1995. Regulation of interleukin 12 p40 expression through an NF-κB half-site Mol. Cell. Biol. 15:5258-5267.
55. Nakane, A., T. Minagawa, and K. Kato. 1988. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect. Immun. 56:2563-2569.
56. Nakane, A., T. Minagawa, M. Kohanawa, Y. Chen, H. Sato, M. Moriyama, and N. Tsuruoka. 1989. Interactions between endogenous gamma interferon and tumor necrosis factor in host resistance against primary and secondary Listeria monocytogenes infections. Infect. Immun. 57:3331-3337.
57. Narumi, S., J. M. Tebo, J. H. Finke, and T. A. Hamilton. 1992. IFN-γ and IL-2 cooperatively activate NF-κB in murine peritoneal macrophages. J. Immunol. 149:529-534.
58. Neish, A. S., M. A. Read, D. Thanos, R. Pine, T. Maniatis, and T. Collins. 1995. Endothelial interferon regulatory factor 1 cooperates with NF-κB as a transcriptional activator of vascular cell adhesion molecule 1. Mol. Cell Biol. 15:2558-2569.
59. Ohmori, Y., and T. A. Hamilton. 1995. The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α. J. Immunol. 154:5235-5244.
60. Pellegrini, S., and C. Schindler. 1993. Early events in signalling by interferons. Trends Biochcm. Sci. 18:338-342.
61. Pestka, S., J. A. Langer, K. C. Zoon, and C. E. Samuel. 1987. Interferons and their actions. Annu. Rev. Biochem. 56:727-777.
62. Pfeffer, K., T. Matsuyama, T. M. Kündig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegman, P. S. Ohashi, M. Krönke, and T. W. Mak. 1993. Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
63. Pober, J. S., and R. S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70:427-451.
64. Rothe, J., W. Lesslauer, H. Lötscher, Y. Lang, P. Koebel, F. Köntgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
65. Ruggiero, V., J. Tavernier, W. Fiers, and C. Baglioni. 1986. Induction of the synthesis of tumor necrosis factor receptors by interferon-γ. J. Immunol. 136:2445-2450.
66. Sancéau, J., G. Merlin, and J. Wietzerbin. 1992. Tumor necrosis factor-α and IL-6 up-regulate IFN-γ receptor gene expression in human monocytic THP-1 cells by transcriptional and post-transcriptional mechanisms. J. Immunol. 149:1671-1677.
67. Sancéau, J., T. Kaisho, T. Hirano, and J. Wietzerbin. 1995. Triggering of the human interleukin-6 gene by interferon-γ and tumor necrosis factor-α in monocytic cells involves cooperation between interferon regulatory factor-1, NFκB and Sp1 transcription factors. J. Biol. Chem. 270:27920-27931.
68. Scheinman, R. I., A. A. Beg, and A. S. Baldwin, Jr. 1993. NF-κB p100 (Lyt-10) is a component of H2TF1 and can function as an IκB-like molecule. Mol. Cell. Biol. 13:6089-6101.
69. Scherer, D. C., J. A. Brockman, Z. Chen, T. Maniatis, and D. Ballard. 1995. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92:11259-11263.
70. Schindler, C., and J. E. Darnell, Jr. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621-651.
71. Sha, W., H. C. Liou, E. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330.
72. Sidhu, R. S., and A. P. Bollon. 1993. Tumor necrosis factor activities and cancer therapy - a perspective. Pharmacol. Ther. 57:79-128.
73. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
74. Singh, S., B. G. Darnay, and B. B. Aggarwal. 1996. Site-specific tyrosine phosphorylation of IκBα negatively regulates its inducible phosphorylation and degradation. J. Biol. Chem. 271:31049-31054.
75. Spink, J., J. Cohen, and T. J. Evans. 1995. The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. J. Biol. Chem. 270:29541-29547.
76. Suyang, H., R. Phillips, I. Douglas, and S. Ghosh. 1996. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB. Mol. Cell. Biol. 16:5444-5449.
77. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573-582.
78. Tiisala, S., M.-L. Majuri, O. Carpén, and R. Renkonen. 1994. Genistein enhances the ICAM-mediated adhesion by inducing the expression of ICAM-1 and its counter-receptors. Biochem. Biophys. Res. Commun. 203: 443-449.
79. Tsujimoto, M., Y. K. Yip, and J. Vilcek. 1986. Interferon-γ enhances expression of cellular receptors for tumor necrosis factor. J. Immunol. 136:2441-2444.
80. Weih, F., D. Carrasco, S. Durham, D. Barton, C. Rizzo, R. P. Ryseck, S. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331-340.
81. Weil, R., C. Laurent-Winter, and A. Israël. 1997. Regulation of IκBβ degradation. J. Biol. Chem. 272:9942-9949.
82. Xie, Q.-W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269: 4705-4708.
83. Yasumoto, K., S.-I. Okamoto, N. Mukaida, S. Murakami, M. Mai, and K. Matsushima. 1992. Tumor necrosis factor α and interferon γ synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 267:22506-22511.